Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bollani, Lina, Baraldi, Eugenio, Chirico, Gaetano, Dotta, Andrea, Lanari, Marcello, Del Vecchio, Antonello, Manzoni, Paolo, Boldrini, Antonio, Paolillo, Piermichele, Di Fabio, Sandra, Orfeo, Luigi, Stronati, Mauro, Romagnoli, Costantino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681171/
https://www.ncbi.nlm.nih.gov/pubmed/26670908
http://dx.doi.org/10.1186/s13052-015-0203-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681171/
https://www.ncbi.nlm.nih.gov/pubmed/26670908
http://dx.doi.org/10.1186/s13052-015-0203-x

Ejemplares similares